STERIS plc

STERIS plc Equity

The The Equity of STERIS plc (STE) as of Oct 29, 2026 is 7.18 B USD. In the previous year, The Equity was 6.60 B USD — a change of 8.79% (higher).

Equity

7.18 BUSD

YoY

8.79%

Last updated:

In 2026, STERIS plc's equity was 7.18 B USD, a 8.79% increase from the 6.60 B USD equity in the previous year.

The STERIS plc Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
3.19 B USD
Jan 1, 2020
3.41 B USD
Jan 1, 2021
3.89 B USD
Jan 1, 2022
6.53 B USD
Jan 1, 2023
6.09 B USD
Jan 1, 2024
6.30 B USD
Jan 1, 2025
6.60 B USD
Jan 1, 2026
7.18 B USD
The STERIS plc Equity history
YEAREquityYoY
7.18 BUSD+8.79%
6.60 BUSD+4.78%
6.30 BUSD+3.53%
6.09 BUSD-6.82%
6.53 BUSD+67.86%
3.89 BUSD+14.23%
3.41 BUSD+6.93%
3.19 BUSD-0.98%
3.22 BUSD+14.49%
2.81 BUSD-7.53%
3.04 BUSD+183.04%
1.07 BUSD+3.11%
1.04 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

STERIS plc Stock analysis

What does STERIS plc do? Steris plc is a global provider of products and services in the field of sterilization and disinfection. The company was founded in the United States in 1985 and became an Irish company with headquarters in Dublin in 2015. Steris plc's business model is based on offering solutions for the sterilization and disinfection of medical devices, rooms, and instruments. The company offers a wide range of products and services, including machines and equipment, chemicals and consumables, as well as consulting and training services. Steris plc is divided into several business segments, each focused on specific customer needs. The Healthcare Products division provides solutions for hospitals and medical facilities, including cleaning and disinfecting agents, surgical instruments, and sterilization equipment. The Life Sciences division offers products and services for biotechnology, pharmaceutical, and medical device companies, such as cleaning and sterilization services that comply with FDA regulations. Another important area of Steris plc is Applied Sterilization Technologies, which offers customized solutions for customers in various industries. These range from sterilizing food and beverages to industrial applications such as sterilizing materials in the automotive industry. In addition to offering products and services, Steris plc also specializes in consulting and training for customers. The company provides a wide range of training and seminars to ensure optimal use of sterilization and disinfection products and maximize safety and efficiency. One of Steris plc's most well-known products is the "STERIS V-PRO" system. This system is an automated sterilizer that allows for rapid sterilization of medical instruments and devices. Unlike traditional sterilization methods, this system uses high-energy waves for sterilization, making it possible to sterilize sensitive instruments and materials that may not be possible with conventional methods. Another product of Steris plc is the "SYSTEM 1" sterilization process, used for the sterilization of flexible endoscopes. This process is particularly efficient and effective, sterilizing the endoscopes quickly and thoroughly without causing damage during the process. Steris plc is a pioneer in the field of sterilization and disinfection and has established itself as a leading provider in this field. The company aims to develop innovative solutions to help customers worldwide meet their sterilization and disinfection requirements optimally. STERIS plc is one of the most popular companies on Eulerpool.

Equity Details

Analyzing STERIS plc's Equity

STERIS plc's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding STERIS plc's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating STERIS plc's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

STERIS plc's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in STERIS plc’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about STERIS plc stock

The Equity of STERIS plc is 7.18 B USD in 2026.

The Equity of STERIS plc changed from 6.60 B USD to 7.18 B USD, representing a 8.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity STERIS plc since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's STERIS plc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — STERIS plc

All Key Metrics — STERIS plc